Articles

On 20 November 2019 the TGA issued a direction notice to Cat Media concerning its advertising of Fatblaster Clinical

Mundipharma Pty Ltd has paid penalties of $302,400 in response to 24 infringement notices issued by the TGA

Consumer Healthcare Products Australia to handle all medicine advertising pre-approval applications

The Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications

The Therapeutic Goods Administration is aware that a member of the public has purported to be a Commonwealth public official during a recent incident in Melbourne

Changes are coming in November to the advertising pre-approval arrangements for some complementary medicines advertisements

The TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices

Direction Notice issued to cease advertising of therapeutic goods not entered in the ARTG

Direction Notice issued to cease advertising of unregistered therapeutic goods to consumers

The Federal Court has imposed substantial penalties on Peptide Clinics Australia

Reasons for releasing guidance and how it was developed

Court action continues against Peptide Clinics Australia for alleged advertising breaches

Do your research before consenting to live blood analysis, electrodermal testing and other related tests

This update implements feedback from stakeholders to make the database more user-friendly

Direction Notice issued to cease advertisement of prescription and illegal products